IDK1 is a rat monoclonal antibody against hypoglycosylated bone sialoprotein with application as biomarker and therapeutic agent in breast cancer skeletal metastasis

Changes in glycosylation are salient features of cancer cells. Here, we report on the diagnostic and therapeutic properties of IDK1, an antibody against tumour associated, hypoglycosylated bone sialoprotein (hypo‐BSP). The affinity of the rat monoclonal antibody IDK1 for hypo‐BSP, as determined by m...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Pathol Clin Res
Autori principali: Zepp, Michael, Kovacheva, Marineta, Altankhuyag, Munkhtsetseg, Westphal, Gabriela, Berger, Irina, Gather, Katharina S, Hilbig, Heidegard, Neuhaus, Jochen, Hänsch, Gertrud M, Armbruster, Franz P, Berger, Martin R
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2017
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5783975/
https://ncbi.nlm.nih.gov/pubmed/29416877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cjp2.88
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi